系统综述评估创伤中REBOA使用算法并确定患者选择共识
本系统综述遵循PRISMA指南,系统检索2015至2022年发表的创伤患者REBOA选择临床实践指南,并纳入一个七中心REBOA协作组的机构指南,共分析10个已发表算法和7个机构指南。结果显示,对血制品复苏无效的钝性或穿透性躯干不可压迫性出血创伤患者使用REBOA存在广泛共识;但在早期股总动脉穿刺和REBOA置入的精确收缩压触发值,以及REBOA用于创伤性心搏骤停和胸部或四肢出血控制方面,各算法存在分歧。作者指出,机构指南的便利样本可能低估了患者选择的变异性,部分选择差异反映了个体实践环境。证据等级为5级系统综述。
要点
- 对血制品复苏无效的钝性或穿透性创伤躯干不可压迫性出血患者,使用REBOA存在广泛共识(10个已发表算法和7个机构指南)。
- 各算法在早期股总动脉穿刺和REBOA置入的精确收缩压触发值上存在分歧。
- REBOA用于创伤性心搏骤停以及胸部或四肢出血控制方面,各算法不一致。
- 机构指南的便利样本可能低估患者选择变异性,部分差异反映个体实践环境。
- 证据等级为Level 5,系统综述。
适用人群与场景
- 钝性或穿透性创伤患者,伴躯干不可压迫性出血且对血制品复苏无效。
研究设计与关键结果
- 系统综述遵循PRISMA指南,纳入2015至2022年发表的10个REBOA患者选择算法及一个七中心REBOA协作组的7个机构指南。
- 对血制品复苏无效的钝性和穿透性创伤患者使用REBOA存在广泛共识。
- 各算法在早期股总动脉穿刺和REBOA置入的精确收缩压触发值上存在分歧。
- 各算法在REBOA用于创伤性心搏骤停及胸部或四肢出血控制上存在分歧。
- 机构指南的便利样本可能低估患者选择变异性,部分差异反映个体实践环境。
证据类型、等级与局限
- 证据类型:系统综述。
- 证据等级:Level 5。
- 局限:机构指南的便利样本可能低估患者选择变异性。
对床旁实践的改变
- 对血制品复苏无效的钝性或穿透性创伤躯干不可压迫性出血患者,可参考广泛共识使用REBOA。
- 早期股总动脉穿刺和REBOA置入的收缩压触发值尚无统一标准,各算法存在分歧。
- REBOA用于创伤性心搏骤停及胸部或四肢出血控制尚存分歧,选择需结合个体实践环境。
指南或共识出处
- 系统综述:评估创伤中REBOA使用算法并确定患者选择共识,发表于Trauma Surg Acute Care Open。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patient selection for resuscitative endovascular balloon occlusion of the aorta (REBOA) has evolved during the last decade. A recent multicenter collaboration to implement the newest generation REBOA balloon catheter identified variability in patient selection criteria. The aims of this systematic review were to compare recent REBOA patient selection guidelines and to identify current areas of consensus and variability.
METHODS: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review of clinical practice guidelines for REBOA patient selection in trauma. Published algorithms from 2015 to 2022 and institutional guidelines from a seven-center REBOA collaboration were compiled and synthesized.
RESULTS: Ten published algorithms and seven institutional guidelines on REBOA patient selection were included. Broad consensus exists on REBOA deployment for blunt and penetrating trauma patients with non-compressible torso hemorrhage refractory to blood product resuscitation. Algorithms diverge on precise systolic blood pressure triggers for early common femoral artery access and REBOA deployment, as well as the use of REBOA for traumatic arrest and chest or extremity hemorrhage control.
CONCLUSION: Although our convenience sample of institutional guidelines likely underestimates patient selection variability, broad consensus exists in the published literature regarding REBOA deployment for blunt and penetrating trauma patients with hypotension not responsive to resuscitation. Several areas of patient selection variability reflect individual practice environments.
LEVEL OF EVIDENCE: Level 5, systematic review.
参考来源
- Maiga AW, Kundi R, Morrison JJ, et al. Systematic review to evaluate algorithms for REBOA use in trauma and identify a consensus for patient selection. Trauma Surg Acute Care Open. 2022. PMID: 36578977. doi:10.1136/tsaco-2022-000984
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。